Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis

Objectives: This network meta-analysis aimed to compare the efficacy and safety of fluoroquinolone (FQ) monotherapy, β-lactam (BL) monotherapy and β-lactam/macrolide (BL-M) combination therapy in hospitalized patients with community-acquired pneumonia (CAP). Methods: Pubmed, Embase and the Cochrane...

Full description

Bibliographic Details
Main Authors: Lu-Yan Xu, Can-Can Wang, Xiao-Xiao Peng, Ying Jiao, Cui-Zhu Zhao, Li Zhang, Li Ma
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716522001138
_version_ 1811274063137472512
author Lu-Yan Xu
Can-Can Wang
Xiao-Xiao Peng
Ying Jiao
Cui-Zhu Zhao
Li Zhang
Li Ma
author_facet Lu-Yan Xu
Can-Can Wang
Xiao-Xiao Peng
Ying Jiao
Cui-Zhu Zhao
Li Zhang
Li Ma
author_sort Lu-Yan Xu
collection DOAJ
description Objectives: This network meta-analysis aimed to compare the efficacy and safety of fluoroquinolone (FQ) monotherapy, β-lactam (BL) monotherapy and β-lactam/macrolide (BL-M) combination therapy in hospitalized patients with community-acquired pneumonia (CAP). Methods: Pubmed, Embase and the Cochrane Library were searched for randomized controlled trials (RCTs) comparing FQ monotherapy, BL monotherapy and BL-M combination therapy up to July 2021. The outcomes of interest included all-cause mortality, clinical success, microbiological success and drug-related adverse events. The summary relative risks (RRs) were estimated using pairwise and Bayesian network meta-analysis. Results: A total of 12 RCTs involving 5009 patients were included. In pairwise meta-analysis, no significant differences were found among FQ monotherapy, BL monotherapy and BL-M dual therapy for all-cause mortality, clinical success or microbiological success. FQ monotherapy was associated with fewer adverse events compared with BL-M therapy (RR 0.80, 95% confidence interval [CI] 0.66–0.98). The network meta-analysis showed that there was no significant difference observed among FQ monotherapy, BL monotherapy and BL-M dual therapy regarding all the outcomes. Conclusion: FQ monotherapy, BL monotherapy and BL-M combination therapy demonstrated similar efficacy and safety for hospitalized patients with CAP in this network meta-analysis. Due to the limitations of quality and quantity of the included studies, it is difficult to make a definitive recommendation before more large-scale and high-quality RCTs are conducted.
first_indexed 2024-04-12T23:12:11Z
format Article
id doaj.art-e5665a9a1cf94551bc63cac9b8e07776
institution Directory Open Access Journal
issn 2213-7165
language English
last_indexed 2024-04-12T23:12:11Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Journal of Global Antimicrobial Resistance
spelling doaj.art-e5665a9a1cf94551bc63cac9b8e077762022-12-22T03:12:47ZengElsevierJournal of Global Antimicrobial Resistance2213-71652022-09-013019Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysisLu-Yan Xu0Can-Can Wang1Xiao-Xiao Peng2Ying Jiao3Cui-Zhu Zhao4Li Zhang5Li Ma6Corresponding author: Department of General Medicine, Daxing District People's Hospital, Capital Medical University, Beijing 102600, China.; Department of General Medicine, Daxing District People's Hospital, Capital Medical University, Beijing, ChinaDepartment of General Medicine, Daxing District People's Hospital, Capital Medical University, Beijing, ChinaDepartment of General Medicine, Daxing District People's Hospital, Capital Medical University, Beijing, ChinaDepartment of General Medicine, Daxing District People's Hospital, Capital Medical University, Beijing, ChinaDepartment of General Medicine, Daxing District People's Hospital, Capital Medical University, Beijing, ChinaDepartment of General Medicine, Daxing District People's Hospital, Capital Medical University, Beijing, ChinaDepartment of General Medicine, Daxing District People's Hospital, Capital Medical University, Beijing, ChinaObjectives: This network meta-analysis aimed to compare the efficacy and safety of fluoroquinolone (FQ) monotherapy, β-lactam (BL) monotherapy and β-lactam/macrolide (BL-M) combination therapy in hospitalized patients with community-acquired pneumonia (CAP). Methods: Pubmed, Embase and the Cochrane Library were searched for randomized controlled trials (RCTs) comparing FQ monotherapy, BL monotherapy and BL-M combination therapy up to July 2021. The outcomes of interest included all-cause mortality, clinical success, microbiological success and drug-related adverse events. The summary relative risks (RRs) were estimated using pairwise and Bayesian network meta-analysis. Results: A total of 12 RCTs involving 5009 patients were included. In pairwise meta-analysis, no significant differences were found among FQ monotherapy, BL monotherapy and BL-M dual therapy for all-cause mortality, clinical success or microbiological success. FQ monotherapy was associated with fewer adverse events compared with BL-M therapy (RR 0.80, 95% confidence interval [CI] 0.66–0.98). The network meta-analysis showed that there was no significant difference observed among FQ monotherapy, BL monotherapy and BL-M dual therapy regarding all the outcomes. Conclusion: FQ monotherapy, BL monotherapy and BL-M combination therapy demonstrated similar efficacy and safety for hospitalized patients with CAP in this network meta-analysis. Due to the limitations of quality and quantity of the included studies, it is difficult to make a definitive recommendation before more large-scale and high-quality RCTs are conducted.http://www.sciencedirect.com/science/article/pii/S2213716522001138Community-acquired pneumoniaβ-lactamsMacrolidesFluoroquinolonesNetwork meta-analysis
spellingShingle Lu-Yan Xu
Can-Can Wang
Xiao-Xiao Peng
Ying Jiao
Cui-Zhu Zhao
Li Zhang
Li Ma
Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
Journal of Global Antimicrobial Resistance
Community-acquired pneumonia
β-lactams
Macrolides
Fluoroquinolones
Network meta-analysis
title Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
title_full Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
title_fullStr Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
title_full_unstemmed Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
title_short Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
title_sort empirical antibiotic treatment strategies for community acquired pneumonia a network meta analysis
topic Community-acquired pneumonia
β-lactams
Macrolides
Fluoroquinolones
Network meta-analysis
url http://www.sciencedirect.com/science/article/pii/S2213716522001138
work_keys_str_mv AT luyanxu empiricalantibiotictreatmentstrategiesforcommunityacquiredpneumoniaanetworkmetaanalysis
AT cancanwang empiricalantibiotictreatmentstrategiesforcommunityacquiredpneumoniaanetworkmetaanalysis
AT xiaoxiaopeng empiricalantibiotictreatmentstrategiesforcommunityacquiredpneumoniaanetworkmetaanalysis
AT yingjiao empiricalantibiotictreatmentstrategiesforcommunityacquiredpneumoniaanetworkmetaanalysis
AT cuizhuzhao empiricalantibiotictreatmentstrategiesforcommunityacquiredpneumoniaanetworkmetaanalysis
AT lizhang empiricalantibiotictreatmentstrategiesforcommunityacquiredpneumoniaanetworkmetaanalysis
AT lima empiricalantibiotictreatmentstrategiesforcommunityacquiredpneumoniaanetworkmetaanalysis